<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>guide &#8211; Science</title>
	<atom:link href="https://scienmag.com/tag/guide/feed/" rel="self" type="application/rss+xml" />
	<link>https://scienmag.com</link>
	<description></description>
	<lastBuildDate>Sat, 17 Oct 2026 01:36:20 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://scienmag.com/wp-content/uploads/2024/07/cropped-scienmag_ico-32x32.jpg</url>
	<title>guide &#8211; Science</title>
	<link>https://scienmag.com</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">73899611</site>	<item>
		<title>Circulating Tumor Cells and Tumor Size Combine to Guide Liver Cancer Surgery Margins</title>
		<link>https://scienmag.com/circulating-tumor-cells-and-tumor-size-combine-to-guide-liver-cancer-surgery-margins/</link>
		
		<dc:creator><![CDATA[Nathaniel Bowman]]></dc:creator>
		<pubDate>Sat, 17 Oct 2026 01:36:20 +0000</pubDate>
				<category><![CDATA[Medicine]]></category>
		<category><![CDATA[Science News]]></category>
		<category><![CDATA[analysis]]></category>
		<category><![CDATA[cells]]></category>
		<category><![CDATA[Circulating]]></category>
		<category><![CDATA[circulating tumor cells]]></category>
		<category><![CDATA[combined]]></category>
		<category><![CDATA[early-stage liver cancer]]></category>
		<category><![CDATA[guide]]></category>
		<category><![CDATA[hepatocellular carcinoma]]></category>
		<category><![CDATA[liver cancer]]></category>
		<category><![CDATA[liver cancer recurrence]]></category>
		<category><![CDATA[liver cirrhosis]]></category>
		<category><![CDATA[liver surgery planning]]></category>
		<category><![CDATA[margin]]></category>
		<category><![CDATA[personalized surgical approach]]></category>
		<category><![CDATA[preoperative]]></category>
		<category><![CDATA[resection]]></category>
		<category><![CDATA[size]]></category>
		<category><![CDATA[status]]></category>
		<category><![CDATA[surgical resection margins]]></category>
		<category><![CDATA[tumor]]></category>
		<category><![CDATA[tumor micro-metastasis detection]]></category>
		<category><![CDATA[tumor recurrence prediction]]></category>
		<category><![CDATA[tumor size]]></category>
		<category><![CDATA[width]]></category>
		<guid isPermaLink="false">https://scienmag.com/?p=292262</guid>

					<description><![CDATA[A multicenter retrospective study of 383 patients shows that preoperative circulating tumor cell status combined with tumor diameter can guide resection margin width in solitary hepatocellular carcinoma, sparing low-risk patients excessive liver removal while identifying those who benefit from wider margins.]]></description>
										<content:encoded><![CDATA[<p>Hepatocellular carcinoma (HCC) is the sixth most common malignancy worldwide and the third leading cause of cancer death, and for patients with early-stage disease, surgical resection remains the mainstay of treatment. Yet even after apparently complete tumor removal, the five-year recurrence-free survival rate hovers between 50 and 70 percent, a figure that severely limits long-term survival. The central paradox of liver cancer surgery has always been this: cutting a wider margin of healthy tissue around the tumor may sweep away microscopic residual disease, but it also removes precious liver parenchyma that a cirrhotic patient cannot afford to lose. Now, a multicenter retrospective study published in Frontiers in Oncology offers what its authors describe as the first combined preoperative tool to resolve that dilemma, using two simple, objective measurements—circulating tumor cell (CTC) status and tumor diameter—to decide, before the first incision, exactly how wide the resection margin should be.</p>
<p>The research team, led by surgeons from Zhongshan People&#8217;s Hospital and Shenzhen Longhua District People&#8217;s Hospital in China, analyzed 383 patients who underwent radical resection of solitary HCC with tumors no larger than 5 centimeters. Every patient had preoperative CTC testing performed three days before surgery, using a technique that combines negative immunomagnetic enrichment with immunofluorescence in situ hybridization. In this method, magnetic beads coated with antibodies against CD45—a marker found on white blood cells—are used to strip away leukocytes from a 5-milliliter peripheral blood sample, enriching the rare malignant cells that have entered the bloodstream through epithelial-mesenchymal transition. The remaining cells are then fixed on slides, hybridized with fluorescent probes targeting the centromeres of chromosomes 1 and 8, stained with DAPI, and counted under a fluorescence microscope. A count of one or more CTCs per sample defined CTC-positive status, a threshold the researchers found correlated strongly with microvascular invasion (MVI), the pathological hallmark of tumor aggressiveness in HCC.</p>
<p>The clinical significance of MVI cannot be overstated. From a pathological standpoint, an HCC lesion is not merely the visible tumor mass; it includes microscopic tumor cell nests invading nearby blood vessels, which a narrow resection margin cannot reliably remove. Previous studies have shown that wide margins reduce early postoperative recurrence in patients with MVI, but offer no such advantage in those without it. The problem has been that MVI can only be confirmed definitively after surgery, when the specimen is examined under a microscope—far too late to guide the surgeon&#8217;s hand. Imaging-based prediction models exist, but they lack standardized criteria and show limited accuracy, while subjective assessments such as tumor capsule integrity depend heavily on equipment quality and observer judgment. What the new study demonstrates is that CTC status, detectable in a simple blood draw, serves as a preoperative proxy for MVI, and when combined with tumor diameter measured on routine contrast-enhanced CT or MRI, it creates a decision framework that is both objective and minimally invasive.</p>
<p>The statistical architecture of the study was rigorous. All patients were stratified by tumor size (3 centimeters or less versus more than 3 centimeters) and CTC status (positive versus negative), then further divided by margin width—narrow margins defined as less than 1 centimeter and wide margins as 1 centimeter or more, based on the pathologist-reported shortest macroscopic distance from the tumor edge to the line of transection. Kaplan-Meier survival curves and log-rank tests compared recurrence-free survival (RFS) and overall survival (OS) between groups, while univariate and multivariate Cox regression models identified independent risk factors. A landmark analysis with a 24-month cutoff distinguished early from late recurrence, reflecting the understanding that early recurrences arise from residual microscopic disease while late recurrences more often represent de novo tumors in the diseased liver.</p>
<p>The results revealed a striking stratified effect. In the entire cohort, both tumor diameter and CTC status emerged as independent predictors of RFS and OS. But when the researchers drilled into tumor-size subgroups, something unexpected appeared. For patients with tumors 3 centimeters or smaller—179 patients in total—margin width had no effect on RFS or OS, regardless of CTC status. The MVI rate in this group was only 14.5 percent, and based on multicenter pathological data suggesting that MVI lesions extending more than 1 centimeter from the main tumor account for roughly 28 percent of all MVI in small HCC, the researchers calculated that MVI beyond the 1-centimeter threshold likely occurs in fewer than 4 percent of these patients. In other words, a narrow margin is almost always sufficient to clear the microscopic disease in small tumors, and pursuing wider excision offers no survival benefit while sacrificing liver tissue that cirrhotic patients need to preserve.</p>
<p>The picture changed dramatically for patients with tumors larger than 3 centimeters—204 patients in this subgroup. Here, the MVI rate jumped to 43 percent, consistent with prior findings that tumor size predicts both the incidence and the extent of vascular invasion. When the researchers stratified this group by CTC status, the effect of margin width split cleanly. Among CTC-negative patients with larger tumors, narrow and wide margins produced comparable RFS and OS, with no statistically significant difference. But among CTC-positive patients with tumors exceeding 3 centimeters, wide margins yielded significantly better RFS and OS than narrow margins. Moreover, the landmark analysis showed that wide margins in this CTC-positive subgroup specifically reduced early postoperative recurrence—recurrence within 24 months—while having no effect on late recurrence. This finding aligns precisely with the biological mechanism: early recurrences stem from minimal residual disease left behind at the resection margin, and in patients whose tumors are both large and shedding malignant cells into the bloodstream, that residual burden is substantial enough that only a wider excision can remove it.</p>
<p>The correlation between CTC status and MVI held across both tumor-size groups, reinforcing the biological plausibility of the framework. In patients with tumors 3 centimeters or smaller, the CTC-positive rate was 14.5 percent, and CTC-positive status correlated with MVI at a statistically significant level. In the larger-tumor group, the CTC-positive rate rose to 43.1 percent, and the correlation with MVI was even stronger. Notably, CTC status showed no significant association with other clinicopathological variables, including alpha-fetoprotein levels and tumor differentiation grade, suggesting that it captures a distinct dimension of tumor biology—specifically, the propensity for vascular invasion and hematogenous dissemination—that traditional serum markers and histological grading do not fully reflect.</p>
<p>The study&#8217;s authors frame their findings within the broader concept of precision medicine in hepatobiliary surgery. By identifying patients who do not need wide margins—those with small tumors regardless of CTC status, and those with larger tumors that are CTC-negative—surgeons can preserve more functional liver parenchyma, reducing the risk of postoperative liver failure and increasing the option of repeat resection or other multimodal therapies if recurrence does occur. Conversely, for the smaller subset of patients with large, CTC-positive tumors, the data argue for pursuing wide margins, or alternatively, for using preoperative adjuvant therapy to reduce tumor burden before attempting an extended resection. Both variables—CTC count from a peripheral blood draw and tumor diameter from standard cross-sectional imaging—are available before the operation, are objective, and involve minimal patient discomfort, making the framework readily implementable in clinical practice without specialized equipment beyond the CTC detection platform.</p>
<p>The researchers acknowledge important limitations. The retrospective design carries inherent biases and confounding factors that only a prospective study with a larger sample size can eliminate. The cohort was overwhelmingly Chinese and hepatitis B virus-related, raising questions about whether the conclusions apply to non-Asian populations or to patients with hepatitis C-related or alcohol-related HCC. CTC counts may fluctuate over time within the same patient, introducing temporal heterogeneity. The median follow-up of 30 months, while adequate for capturing early recurrence patterns, is insufficient for robust long-term overall survival conclusions beyond five years. And the cost of CTC detection remains high in some regions, though the authors expect this to decrease as detection methods improve. The findings also apply specifically to patients with solitary tumors no larger than 5 centimeters, the population in which the resection margin dilemma is most acute.</p>
<p>Despite these caveats, the study represents a meaningful advance in a field where the optimal margin width has been debated for decades without consensus. Previous attempts to stratify patients by tumor size alone produced contradictory results, with some groups reporting survival benefits from wide margins across all tumor diameters and others, including a well-known Hong Kong study, finding no benefit in any subgroup. By adding CTC status as a second, biologically grounded variable, the researchers have created a two-parameter decision tool that resolves those contradictions and matches surgical aggressiveness to the actual risk of microscopic residual disease. For a cancer that kills nearly 800,000 people each year, and where the difference between a narrow and a wide margin can determine whether a patient keeps enough liver to survive the operation—or enough liver to undergo a second operation if the tumor returns—that kind of preoperative clarity is not just a statistical finding. It is a roadmap for safer, more individualized liver cancer surgery.</p>
<p><strong>Subject of Research:</strong> Combined analysis of preoperative circulating tumor cells status and tumor size to guide width of resection margin for solitary hepatocellular carcinoma</p>
<p><strong>Article Title:</strong> Combined analysis of preoperative circulating tumor cells status and tumor size to guide width of resection margin for solitary hepatocellular carcinoma</p>
<p><strong>Article References:</strong> Xie, J., Luo, Q., Huang, D., Xia, F., Wu, Z., Zhou, W., Zhang, Q., Tian, F., Liu, C.-Y., Xu, Z., Jiao, X.-T., Zhang, W.-Q., Ali, M., Zhou, Y., &amp; Gao, H. (2026). Combined analysis of preoperative circulating tumor cells status and tumor size to guide width of resection margin for solitary hepatocellular carcinoma. <em>Frontiers in Oncology, 16</em>, Article 1810914. <a href="https://doi.org/10.3389/fonc.2026.1810914" rel="noopener noreferrer">https://doi.org/10.3389/fonc.2026.1810914</a></p>
<p><strong>Image Credits:</strong> AI Generated</p>
<p><strong>DOI:</strong> <a href="https://doi.org/10.3389/fonc.2026.1810914" rel="noopener noreferrer">10.3389/fonc.2026.1810914</a></p>
<p><strong>Keywords:</strong> Combined, analysis, preoperative, circulating, tumor, cells, status, size, guide, width, resection, margin</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">292262</post-id>	</item>
		<item>
		<title>Using a trait-based framework to characterize farmed seaweeds and guide selection of new candidates</title>
		<link>https://scienmag.com/using-a-trait-based-framework-to-characterize-farmed-seaweeds-and-guide-selection-of-new-candidates/</link>
		
		<dc:creator><![CDATA[Violet Maxwell]]></dc:creator>
		<pubDate>Fri, 11 Sep 2026 22:59:52 +0000</pubDate>
				<category><![CDATA[Marine]]></category>
		<category><![CDATA[aquaculture]]></category>
		<category><![CDATA[candidate species identification]]></category>
		<category><![CDATA[candidates]]></category>
		<category><![CDATA[characterize]]></category>
		<category><![CDATA[crop improvement]]></category>
		<category><![CDATA[ecological screening]]></category>
		<category><![CDATA[farmed]]></category>
		<category><![CDATA[framework]]></category>
		<category><![CDATA[functional traits]]></category>
		<category><![CDATA[guide]]></category>
		<category><![CDATA[marine biotechnology]]></category>
		<category><![CDATA[marine plant physiology]]></category>
		<category><![CDATA[Scientific Research]]></category>
		<category><![CDATA[Seaweed farming]]></category>
		<category><![CDATA[seaweed species characterization]]></category>
		<category><![CDATA[seaweeds]]></category>
		<category><![CDATA[selection]]></category>
		<category><![CDATA[species selection]]></category>
		<category><![CDATA[sustainable aquaculture]]></category>
		<category><![CDATA[trait-based]]></category>
		<category><![CDATA[trait-based framework]]></category>
		<guid isPermaLink="false">https://scienmag.com/?p=193054</guid>

					<description><![CDATA[html Seaweed farming has quietly become one of the fastest-growing sectors of global aquaculture, supplying food, hydrocolloids, fertilizers, animal feed, and emerging markets such as bioplastics and biofuels. Yet the industry's expansion has been shaped less by systematic science than]]></description>
										<content:encoded><![CDATA[<p>html<br />
Seaweed farming has quietly become one of the fastest-growing sectors of global aquaculture, supplying food, hydrocolloids, fertilizers, animal feed, and emerging markets such as bioplastics and biofuels. Yet the industry&#8217;s expansion has been shaped less by systematic science than by tradition: farmers tend to cultivate the species they have always cultivated, and researchers tend to study the species that are already commercially dominant. A new perspective published in npj Ocean Sustainability argues that this inertia is holding the sector back, and that a trait-based framework borrowed from ecology and crop science could transform how candidate seaweed species are identified, compared, and selected for cultivation.</p>
<p>The core idea is deceptively simple. Rather than classifying seaweeds only by taxonomy or by their current commercial status, the framework characterizes each species by measurable functional traits: morphological features such as thallus size and branching, physiological features such as photosynthetic rates and nutrient uptake kinetics, and life-history features such as reproductive strategy and growth seasonality. In terrestrial agriculture, this trait-based approach has underpinned decades of crop improvement and ecological screening, allowing scientists to predict how a plant will perform under specific conditions without having to trial every individual genotype. The authors contend that seaweed science is now mature enough to apply the same logic, turning a scattered body of species-specific observations into a coherent, comparative discipline.</p>
<p>The need for such a framework becomes clear when one considers the structure of the seaweed farming industry. Global production is overwhelmingly concentrated in a handful of genera, including the kelp Saccharina and Undaria, the red algae Pyropia, Eucheuma, Kappaphycus, and Gracilaria, and the green alga Ulva. These cultivated species were largely domesticated from wild populations selected for availability and market demand rather than for optimized performance. Meanwhile, thousands of seaweed species remain uncultivated, many of which may possess traits, such as tolerance to warmer water, resistance to disease, rapid growth, or valuable biochemical compositions, that could make them superior candidates for future farming systems, particularly as ocean temperatures rise and cultivation expands into new biogeographic regions.</p>
<p>At the heart of the proposed approach is the recognition that no single trait determines success in aquaculture. A fast-growing species that cannot withstand wave exposure is a poor candidate for open-ocean farms; a hardy species with slow growth may never achieve commercial yields. Trait-based characterization allows these trade-offs to be made explicit. By compiling data on traits such as growth rate, temperature and salinity tolerance, nutrient requirements, epiphyte and pathogen susceptibility, ease of reproduction in hatcheries, and the mechanical properties of the thallus that determine how well a seaweed handles farm infrastructure, researchers can build comparative profiles that reveal which species are most likely to thrive under particular farming conditions and for particular markets.</p>
<p>The framework also speaks directly to one of the most pressing challenges in the field: climate resilience. Many of today&#8217;s workhorse species are cultivated near the thermal edges of their tolerance, and marine heatwaves have already caused significant crop losses in several producing regions. Selecting new candidates on the basis of thermal tolerance traits, rather than historical yield alone, could help the industry stay ahead of shifting ocean conditions. Similarly, as interest grows in offshore cultivation, where wave action and depth impose demands that nearshore farms do not, traits such as thallus robustness and attachment strength become decisive selection criteria that conventional species lists simply cannot capture.</p>
<p>Beyond environmental matching, trait-based screening can illuminate a species&#8217; potential end-use. Seaweeds are farmed for wildly different purposes: nori for direct human consumption, carrageenan and agar-producing reds for hydrocolloid extraction, kelps for food ingredients and increasingly for applications in livestock feed and methane reduction. The biochemical profile of a species, its polysaccharide content, protein levels, pigment composition, and secondary metabolites, is itself a set of functional traits. Incorporating these biochemical characteristics into the framework means that candidate selection can be aligned with market opportunities from the outset, rather than discovering after years of agronomic development that a species is agronomically suitable but commercially unattractive.</p>
<p>The authors emphasize that building such a framework requires addressing significant data gaps. Trait information for seaweeds is patchy, fragmented across decades of phycological literature, and often measured with inconsistent methods that make cross-species comparison difficult. For many candidate species, even basic parameters such as maximal growth rate or reproductive biology in cultivation are unknown. The paper calls for coordinated efforts to standardize trait measurements, compile existing data into accessible databases, and prioritize trait characterization for species that show early promise. This is a familiar challenge in the history of trait-based ecology, where the value of comparative frameworks grew directly out of sustained investment in standardized measurement across research groups.</p>
<p>Another important dimension of the framework is its potential to support responsible innovation. Introducing new species into cultivation carries ecological risks, including the possibility of escapes, competition with native flora, and disease transmission. The authors argue that trait-based evaluation can incorporate risk-relevant traits, such as a species&#8217; invasive potential, its reproductive dispersal capacity, and its host status for known seaweed pathogens, alongside performance traits. This integrated screening could help regulators and farmers distinguish between candidates whose domestication is ecologically prudent and those whose traits raise red flags, embedding biosafety into the earliest stages of candidate selection rather than treating it as an afterthought.</p>
<p>The social and economic geography of seaweed farming also figures in the analysis. A large share of global production occurs among smallholder coastal communities in Asia, and any expansion of the industry into new species and new regions will need to respect local capacities, infrastructure, and market structures. Traits such as the simplicity of a species&#8217; cultivation cycle, the availability of seedstock, and the labor intensity of farm operations are directly relevant to whether a candidate species can be adopted by small-scale farmers. A framework that formalizes these practical traits alongside biological ones helps ensure that scientific selection translates into real-world adoption rather than remaining an exercise in laboratory optimization.</p>
<p>Looking forward, the trait-based approach opens doors to more quantitative and even predictive tools. As trait databases grow, statistical and machine-learning methods could identify combinations of traits that predict cultivation success, allowing researchers to screen large numbers of candidate species cheaply before committing resources to farm trials. The same data could guide selective breeding programs within promising species, identifying heritable traits that respond to improvement, much as crop breeders have done on land. In this sense, the framework is not merely a sorting exercise but a foundation for the deliberate domestication of a new generation of seaweed crops, bringing a level of intentionality to aquaculture that has so far been rare in the sector.</p>
<p>The broader significance of the work lies in its reframing of what seaweed farming could become. Today&#8217;s industry, for all its impressive growth, rests on a narrow biological base that is vulnerable to disease, climate shocks, and market fluctuations. Diversification is widely recognized as essential, but diversification without a principled selection process risks wasted investment and ecological harm. A trait-based framework offers a shared language for researchers, farmers, investors, and regulators to evaluate candidates systematically, compare trade-offs transparently, and prioritize the species most likely to succeed under the conditions of tomorrow&#8217;s oceans. As pressure mounts to expand sustainable marine food production, the ability to choose the right seaweed for the right place and purpose may prove to be one of the most consequential tools the industry acquires.</p>
<p>The analogy with terrestrial crop science is instructive because it highlights how long the payoff horizon for trait-based approaches can be. In agriculture on land, systematic trait screening preceded the green revolution&#8217;s yield gains by decades, and the seaweed sector is effectively at the beginning of that trajectory. Most cultivated seaweed genera have undergone little deliberate genetic improvement, meaning there may be substantial untapped potential even within currently farmed species once their traits are properly quantified and compared.</p>
<p>The framework also arrives at a moment when demand for seaweed products is diversifying beyond traditional food uses. Emerging applications, from biostimulants to alternative proteins, each favor different biochemical and physiological profiles, which strengthens the case for matching species to end-use through explicit trait data rather than trial and error. A species rich in specific polysaccharides, for example, may justify cultivation under conditions that would be uneconomical for a general-purpose food crop.</p>
<p>Finally, the perspective underscores a cultural shift within phycology itself. Much existing knowledge of seaweed biology resides in ecological studies of wild populations rather than in agronomic trials, and the proposed framework offers a route to translate that ecological understanding into cultivation insight. By treating traits as the common currency between wild ecology and farm performance, researchers can begin predicting how uncultivated species might behave in farm settings before expensive domestication programs begin, potentially shortening the path from ocean to aquaculture for promising new candidates.</p>
<p><strong>Subject of Research:</strong> Using a trait-based framework to characterize farmed seaweeds and guide selection of new candidates</p>
<p><strong>Article Title:</strong> Using a trait-based framework to characterize farmed seaweeds and guide selection of new candidates</p>
<p><strong>Article References:</strong> Fong, C. R., Fong, P., &amp; Froehlich, H. E. (2026). Using a trait-based framework to characterize farmed seaweeds and guide selection of new candidates. <em>npj Ocean Sustainability</em>. <a href="https://doi.org/10.1038/s44183-026-00239-5" rel="noopener noreferrer">https://doi.org/10.1038/s44183-026-00239-5</a></p>
<p><strong>Image Credits:</strong> AI Generated</p>
<p><strong>DOI:</strong> <a href="https://doi.org/10.1038/s44183-026-00239-5" rel="noopener noreferrer">10.1038/s44183-026-00239-5</a></p>
<p><strong>Keywords:</strong> trait-based, framework, characterize, farmed, seaweeds, guide, selection, candidates, scientific research</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">193054</post-id>	</item>
	</channel>
</rss>
